500 related articles for article (PubMed ID: 30187395)
1. Health-related quality of life in people with advanced dementia: a comparison of EQ-5D-5L and QUALID instruments.
Sopina E; Chenoweth L; Luckett T; Agar M; Luscombe GM; Davidson PM; Pond CD; Phillips J; Goodall S
Qual Life Res; 2019 Jan; 28(1):121-129. PubMed ID: 30187395
[TBL] [Abstract][Full Text] [Related]
2. How Should We Capture Health State Utility in Dementia? Comparisons of DEMQOL-Proxy-U and of Self- and Proxy-Completed EQ-5D-5L.
Martin A; Meads D; Griffiths AW; Surr CA
Value Health; 2019 Dec; 22(12):1417-1426. PubMed ID: 31806199
[TBL] [Abstract][Full Text] [Related]
3. An Empirical Comparison of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U in a Post-Hospitalisation Population of Frail Older People Living in Residential Aged Care.
Ratcliffe J; Flint T; Easton T; Killington M; Cameron I; Davies O; Whitehead C; Kurrle S; Miller M; Liu E; Crotty M
Appl Health Econ Health Policy; 2017 Jun; 15(3):399-412. PubMed ID: 27882528
[TBL] [Abstract][Full Text] [Related]
4. An empirical comparison of the measurement properties of the EQ-5D-5L, DEMQOL-U and DEMQOL-Proxy-U for older people in residential care.
Easton T; Milte R; Crotty M; Ratcliffe J
Qual Life Res; 2018 May; 27(5):1283-1294. PubMed ID: 29305782
[TBL] [Abstract][Full Text] [Related]
5. Comparison of EQ-5D-5L and SPVU-5D for measuring quality of life in patients with venous leg ulcers in an Australian setting.
Cheng Q; Kularatna S; Lee XJ; Graves N; Pacella RE
Qual Life Res; 2019 Jul; 28(7):1903-1911. PubMed ID: 30778889
[TBL] [Abstract][Full Text] [Related]
6. Comparing the psychometric properties of EQ-5D-3L and EQ-5D-5L proxy ratings by informal caregivers and a health professional for people with dementia.
Michalowsky B; Hoffmann W; Mohr W; Rädke A; Xie F
Health Qual Life Outcomes; 2022 Oct; 20(1):140. PubMed ID: 36199138
[TBL] [Abstract][Full Text] [Related]
7. Psychometric Properties of EQ-5D-3L and EQ-5D-5L in Cognitively Impaired Patients Living with Dementia.
Michalowsky B; Hoffmann W; Xie F
J Alzheimers Dis; 2021; 83(1):77-87. PubMed ID: 34275901
[TBL] [Abstract][Full Text] [Related]
8. Feasibility and validity of EQ-5D-5L proxy by nurses in measuring health-related quality of life of nursing home residents.
Toh HJ; Yap P; Wee SL; Koh G; Luo N
Qual Life Res; 2021 Mar; 30(3):713-720. PubMed ID: 33067756
[TBL] [Abstract][Full Text] [Related]
9. Exploring self-report and proxy-report quality-of-life measures for people living with dementia in care homes.
Griffiths AW; Smith SJ; Martin A; Meads D; Kelley R; Surr CA
Qual Life Res; 2020 Feb; 29(2):463-472. PubMed ID: 31646416
[TBL] [Abstract][Full Text] [Related]
10. Validation and comparison of 15-D and EQ-5D-5L instruments in a Spanish Parkinson's disease population sample.
García-Gordillo M; del Pozo-Cruz B; Adsuar JC; Sánchez-Martínez FI; Abellán-Perpiñán JM
Qual Life Res; 2014 May; 23(4):1315-26. PubMed ID: 24258254
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
12. Assessing the psychometric performance of EQ-5D-5L in dementia: a systematic review.
Keetharuth AD; Hussain H; Rowen D; Wailoo A
Health Qual Life Outcomes; 2022 Sep; 20(1):139. PubMed ID: 36171595
[TBL] [Abstract][Full Text] [Related]
13. EQ-5D-Y-3L and EQ-5D-Y-5L proxy report: psychometric performance and agreement with self-report.
Fitriana TS; Purba FD; Stolk E; Busschbach JJV
Health Qual Life Outcomes; 2022 Jun; 20(1):88. PubMed ID: 35659313
[TBL] [Abstract][Full Text] [Related]
14. The EQ-5D-5L Is Superior to the -3L Version in Measuring Health-related Quality of Life in Patients Awaiting THA or TKA.
Jin X; Al Sayah F; Ohinmaa A; Marshall DA; Smith C; Johnson JA
Clin Orthop Relat Res; 2019 Jul; 477(7):1632-1644. PubMed ID: 30801280
[TBL] [Abstract][Full Text] [Related]
15. Measurement properties of EQ-5D-3L and EQ-5D-5L in recording self-reported health status in older patients with substantial multimorbidity and polypharmacy.
Bhadhuri A; Kind P; Salari P; Jungo KT; Boland B; Byrne S; Hossmann S; Dalleur O; Knol W; Moutzouri E; O'Mahony D; Murphy KD; Wisselink L; Rodondi N; Schwenkglenks M
Health Qual Life Outcomes; 2020 Sep; 18(1):317. PubMed ID: 32993637
[TBL] [Abstract][Full Text] [Related]
16. Convergent validation of EQ-5D-5L in patients with Parkinson's disease.
Alvarado-Bolaños A; Cervantes-Arriaga A; Rodríguez-Violante M; Llorens-Arenas R; Calderón-Fajardo H; Millán-Cepeda R; Leal-Ortega R; Estrada-Bellmann I; Zuñiga-Ramírez C
J Neurol Sci; 2015 Nov; 358(1-2):53-7. PubMed ID: 26276513
[TBL] [Abstract][Full Text] [Related]
17. Assessing the validity of EQ-5D-5L in people with head & neck cancer: Does a generic quality of life measure perform as well as a disease-specific measure in a patient population?
Davies A; Waylen A; Leary S; Thomas S; Pring M; Janssen B; Beynon R; Lang S; Schimansky S; Hurley K; Ness A
Oral Oncol; 2020 Feb; 101():104504. PubMed ID: 31835074
[TBL] [Abstract][Full Text] [Related]
18. Reliability of the quality of life-aged care consumers (QOL-ACC) and EQ-5D-5L among older people using aged care services at home.
Khadka J; Milte R; Hutchinson C; Cleland J; Ratcliffe J
Health Qual Life Outcomes; 2024 May; 22(1):40. PubMed ID: 38816717
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy.
Wijnen BFM; Mosweu I; Majoie MHJM; Ridsdale L; de Kinderen RJA; Evers SMAA; McCrone P
Eur J Health Econ; 2018 Jul; 19(6):861-870. PubMed ID: 28871490
[TBL] [Abstract][Full Text] [Related]
20. EQ-5D-Y-5L as a patient-reported outcome measure in psychiatric inpatient care for children and adolescents - a cross-sectional study.
Åström M; Krig S; Ryding S; Cleland N; Rolfson O; Burström K
Health Qual Life Outcomes; 2020 Jun; 18(1):164. PubMed ID: 32493419
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
